Adsorption of Pb, Cu, and Ni Ions on Activated Carbon Prepared from Oak Cupules: Kinetics and Thermodynamics Studies.

Agricultural residue-activated carbon and biochar, inexpensive and environmentally friendly adsorbent materials, have recently received significant research attention. This study investigated the potential use of oak cupules in activated carbon form to remove widespread heavy metals (Pb2+, Cu2+, and Ni2+) from wastewater. The oak-activated carbon was prepared from oak cupules and activated with phosphoric acid. Oak-activated carbon was characterized using FTIR, BET analysis, energy-dispersive X-ray spectrometry (EDS), thermogravimetric analysis (TGA), and differential scanning calorimetry (DSC). The Freundlich, Langmuir, and Temkin isotherm models were used to assess the equilibrium data. The impact of various parameters, including pH effect, temperature, adsorbent dose, and contact time, was estimated. The Freundlich model was the most agreeable with Pb2+ adsorption by oak-based activated carbon, and Langmuir was more compatible with Cu2+ and Ni2+. Under optimum conditions, the average maximum removal was 63% Pb2+, 60% Cu2+, and 54% Ni2+ when every ion was alone in the aqueous solution. The removal was enhanced to 98% Pb2+, 72% Cu2+, and 60% Ni2+ when found as a mixture. The thermodynamic model revealed that the adsorption of ions by oak-based activated carbon is endothermic. The pseudo-second-order kinetic best describes the adsorption mechanism in this study; it verifies chemical sorption as the rate-limiting step in adsorption mechanisms. The oak-activated carbon was effective in removing Pb2+, Cu2+, and Ni2+ from wastewater and aqueous solutions.

Liposomes: structure, composition, types, and clinical applications.

Liposomes are now considered the most commonly used nanocarriers for various potentially active hydrophobic and hydrophilic molecules due to their high biocompatibility, biodegradability, and low immunogenicity. Liposomes also proved to enhance drug solubility and controlled distribution, as well as their capacity for surface modifications for targeted, prolonged, and sustained release. Based on the composition, liposomes can be considered to have evolved from conventional, long-circulating, targeted, and immune-liposomes to stimuli-responsive and actively targeted liposomes. Many liposomal-based drug delivery systems are currently clinically approved to treat several diseases, such as cancer, fungal and viral infections; more liposomes have reached advanced phases in clinical trials. This review describes liposomes structure, composition, preparation methods, and clinical applications.

Lipid nanostructures for targeting brain cancer.

Advancements in both material science and bionanotechnology are transforming the health care sector. To this end, nanoparticles are increasingly used to improve diagnosis, monitoring, and therapy. Huge research is being carried out to improve the design, efficiency, and performance of these nanoparticles. Nanoparticles are also considered as a major area of research and development to meet the essential requirements for use in nanomedicine where safety, compatibility, biodegradability, biodistribution, stability, and effectiveness are requirements towards the desired application. In this regard, lipids have been used in pharmaceuticals and medical formulations for a long time. The present work focuses on the use of lipid nanostructures to combat brain tumors. In addition, this review summarizes the literature pertaining to solid lipid nanoparticles (SLN) and nanostructured lipid carriers (LNC), methods of preparation and characterization, developments achieved to overcome blood brain barrier (BBB), and modifications used to increase their effectiveness.